Data and Supplementary Materials for KRAS, BRCA, and TP53 Mutations as Prognostic Biomarkers in Pancreatic Cancer: A Systematic Review and Meta-Analysis
KRAS, BRCA, and TP53 Mutations as Prognostic Biomarkers in Pancreatic Cancer: A Systematic Review and Meta-Analysis1. General InformationStudy Title: KRAS, BRCA, and TP53 Mutations as Prognostic Biomarkers in Pancreatic Cancer: A Systematic Review and Meta-Analysis of Survival OutcomesCorresponding Author: Wahby Mohamm...